| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 36.5 | 38.4 | 43.2 |
| Other income | -0.5 | 0.9 | 1.1 |
| Total income | 36.0 | 39.3 | 44.2 |
| Profit before exceptional items & tax | 2.5 | 3.5 | 3.3 |
| Profit before tax | 2.5 | 3.5 | 3.3 |
| Net profit | 2.0 | 2.4 | 2.0 |
| Operating margin | 6.9% | 8.9% | 7.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -16.70% |
| Revenue, year on year | -15.50% |
BSE results filing, NSE: ARCHITORG. Figures extracted from the filing.
Archit Organosys Ltd: key numbers
- Share price
- ₹62.30
- Market cap
- ₹127.8 Cr
- Revenue (annual)
- ₹140.9 Cr
- Net profit (annual)
- ₹8.03 Cr
- P/E (TTM)
- 17.2×Sector 37.5×
- Promoter holding
- 65.88%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Archit Organosys Ltd
All →Archit Organosys Annual Report
Archit Organosys Limited issued a corrigendum to its FY 2025-26 Annual Report, withdrawing Agenda Items 8, 9, and 10 from the upcoming AGM notice.
Archit Organosys Annual General Meeting
Archit Organosys has withdrawn three agenda items from the upcoming AGM, including an authorised capital increase, an acquisition, and a proposed preferential issue for restructuring.
Archit Organosys Annual General Meeting
Archit Organosys Limited announced its 33rd Annual General Meeting to be held on 30th September 2026. The board recommended a dividend of Re. 1 per share.
Archit Organosys Annual Report
Archit Organosys Ltd has filed its Annual Report for the financial year 2025-26. The submission includes audited financial statements and director's reports for the period.
Archit Organosys Dividend
Archit Organosys has fixed September 23, 2026, as the record date to determine shareholder eligibility for the final dividend recommended for FY 2025-26.
Archit Organosys Capital Structure Change
Archit Organosys will issue 3.72 crore shares via preferential allotment at ₹65/share, totaling ₹242.11 Crore, to acquire a stake in Archit Life Science Limited.
- Value
- ₹242.1 Cr